A recent review published in the journal SmartBot says these DNA nanorobots could one day be capable of delivering drugs to specific locations in the body, capturing viruses like SARS-CoV-2, and even ...

Genome editing is increasingly recognzed as a leading frontier in biomedical research and an essential driver of healthcare innovation. At City University of Hong Kong (CityUHK), a research team has ...

The project team led by Professor Zheng Zongli (right) of CityUHK’s Department of Biomedical Sciences, will focus on liver and cardiovascular genetic diseases, harnessing state-of-the-art “DNA surgery ...

A refined liquid biopsy that accounts for age-related background mutations has enabled clinicians to identify patients with ...

A blood test for circulating tumor human papillomavirus DNA (ctHPVDNA) may improve risk assessment in patients undergoing ...

Assessment of ovarian function suppression (OFS)-containing adjuvant endocrine therapy in premenopausal women by Breast Cancer Index. HR: hormone receptor, HER2: human epidermal growth factor receptor ...

Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP). This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I.

Fragments of tumor DNA circulating in the bloodstream of patients with breast cancer can predict whether they are likely to relapse, especially when samples are taken after the patients have received ...

Nodal burden predicts higher preoperative ctHPVDNA levels, while aggressive pathologic features paradoxically correlate with ...